Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 3/20 | 0.77 |
| ▸ | CDK2 | P24941 | 3/20 | 0.77 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.77 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.77 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.77 |
| ▸ | JAK2 | O60674 | 1/20 | 0.77 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.77 |
| ▸ | ZAP70 | P43403 | 13/20 | 0.71 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.71 |
| ▸ | PRKCG | P05129 | 4/20 | 0.71 |
| ▸ | PRKCB | P05771 | 4/20 | 0.71 |
| ▸ | LCK | P06239 | 4/20 | 0.71 |
| ▸ | PRKCA | P17252 | 4/20 | 0.71 |
| ▸ | PRKCH | P24723 | 4/20 | 0.71 |
| ▸ | PRKCI | P41743 | 4/20 | 0.71 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.71 |
| ▸ | PRKCQ | Q04759 | 4/20 | 0.71 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.71 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.71 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6957358 | 0.88 | PIK3CG (0.60) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL6955263 | 0.86 | PIK3CG (0.59) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL6979315 | 0.85 | CDK2 (0.79) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL4891528 | 0.84 | ZAP70 (0.69) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL2233317 | 0.84 | ZAP70 (0.69) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL6976605 | 0.83 | ZAP70 (1.00) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL4732945 | 0.83 | PIK3CA (0.80) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL6972462 | 0.82 | PIK3CG (0.78) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL6977451 | 0.82 | CDK2 (0.78) | EGFRCDK2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL6978697 | 0.82 | CDK2 (0.78) | EGFRCDK2PIK3CAPIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6552029-B1 | For therapy of rheumatoid arthritis, psoriasis, graft v. host disease, asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, complications following percutaneous transluminal coronary angioplasty, thrombosis | CELLTECH R&D LIMITED (GB) | 2003-04-22 | — | — | US | disclosed |
| EP-0862560-B1 | SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS | CELLTECH THERAPEUTICS LTD (GB) | 2003-04-02 | — | — | EP | disclosed |
| EP-0934304-B1 | 2-PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | CELLTECH THERAPEUTICS LTD (GB) | 2003-02-26 | — | — | EP | disclosed |
| US-6235746-B1 | AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT | CELLTECH THERAPEUTICS, LIMITED (GB) | 2001-05-22 | — | — | US | disclosed |
| US-6114333-A | 2-Pyrimidineamine derivatives and processes for their preparation | CELLTECH THERAPEUTICS LTD. (GB) | 2000-09-05 | — | — | US | disclosed |
| US-5958935-A | Substituted 2-anilinopyrimidines useful as protein kinase inhibitors | CELLTECH THERAPEUTICS LIMITED (GB) | 1999-09-28 | — | — | US | disclosed |
| EP-0934304-A1 | 2-PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | CELLTECH THERAPEUTICS LIMITED (GB) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998018782-A1 | 2-PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | CELLTECH THERAPEUTICS LIMITED (GB) | 1998-05-07 | — | — | WO | disclosed |